Hutch News
Results per Page:
Oncogenic role of a developmentally regulated NTRK2 splice variant
From the Holland Lab, Human Biology Division
Transformative $78M gift to establish new precision oncology institute
Gift will accelerate center’s leadership in the future of cancer research
Holland receives NCI Outstanding Investigator Award
Neuroscientist will tackle genetic abnormalities that drive cancers and could be therapeutic targets
New strategy to weather the (cytokine) storm
From the Gujral Lab, Human Biology Division
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
YAP1 gene fusions are oncogenic drivers in several tumor types and potential therapeutic targets
From the Holland, Paddison, Vasioukhin, and Gujral labs, Human Biology Division
New study shows cancer-causing ‘Frankengene’ mutation could be target for new drugs
This gene is fused to many partner genes in different tumors. Now, scientists know it causes cancer — and how they might intervene
Fred Hutch–led team receives $6M to study deadly brain tumor
Researchers seek deeper understanding of ependymoma biology to aid treatment discovery
Bringing personalized oncology to cancer prediction — and prevention
Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk
Brain cancer subtype caused by single gene fusion
Hutch researchers create genetically relevant model to examine the biology of supratentorial ependymomas
Nanoparticles take immunotherapy in new direction
Hutch scientist to use nanoparticles to reprogram macrophages to tackle brain tumors
Study sheds light on why brain cancers become aggressive and treatment-resistant
New computational method sheds light on how cancer-contributing genes make brain tumors more aggressive and radiation-resistant
Dr. Kevin Cheung receives prestigious ‘Era of Hope’ Scholar Award
$4.1 million, four-year award to advance understanding of breast cancer metastasis
Science to watch in 2018: From immunotherapy to gene therapy, big data to new tech
Fred Hutch experts lend their predictions for the coming year’s advances
Osteopontin: can’t live with it, can’t live without it in glioblastoma
From the Holland Lab, Human Biology Division
6 things to know about glioblastoma
Following Sen. John McCain’s diagnosis, Fred Hutch experts offer ‘the long view’ on brain cancer research
IDH1 mutant (or methylation), stops monocyte migration
From the Holland Lab, Human Biology Division
Good News: Bezos family funding accelerates glioma immunotherapy research
Celebrating faculty and staff achievements
How mutations in a single gene alter the course of a deadly brain cancer
New laboratory study of glioma links more aggressive immune response to poorer prognosis
Single gene alters immune response to deadly brain cancer
A new study of glioma in humans and mice links more aggressive immune response to poorer prognosis